Impact of Sex on the Pharmacokinetics and Pharmacodynamics of 1% Tenofovir Gel

Background. Tenofovir (TFV) gel partially protected against human immunodeficiency virus (HIV) in one but not subsequent trials. The disappointing results were attributed largely to poor adherence. However, timing of gel application relative to sex may impact pharmacokinetics and contribute to outco...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Clin Infect Dis
Main Authors: Herold, Betsy C., Chen, Beatrice A., Salata, Robert A., Marzinke, Mark A., Kelly, Clifton W., Dezzutti, Charlene S., McGowan, Ian, Galaska, Beth, Levy, Lisa, Piper, Jeanna M., Hillier, Sharon, Hendrix, Craig W.
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2016
Assuntos:
HIV/AIDS
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4706638/
https://ncbi.nlm.nih.gov/pubmed/26508513
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/civ913
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados